Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes
Open accessThe DOI matches its Crossref record; 180 of the 182 references it cites were found in a registry or an index; 67 of the 185 sources its claims cite were checked for support.
Abstract
The Ehlers‒Danlos syndromes (EDS) constitute a heterogenous group of connective tissue disorders characterized by joint hypermobility, skin abnormalities, and vascular fragility. The latest nosology recognizes 13 types caused by pathogenic variants in genes encoding collagens and other molecules involved in collagen processing and extracellular matrix (ECM) biology. Classical (cEDS), vascular (vEDS), and hypermobile (hEDS) EDS are the most frequent types. cEDS and vEDS are caused respectively by defects in collagen V and collagen III, whereas the molecular basis of hEDS is unknown. For these disorders, the molecular pathology remains poorly studied. Herein, we review, expand, and compare our previous transcriptome and protein studies on dermal fibroblasts from cEDS, vEDS, and hEDS patients, offering insights and perspectives in their molecular mechanisms. These cells, though sharing a pathological ECM remodeling, show differences in the underlying pathomechanisms. In cEDS and vEDS fibroblasts, key processes such as collagen biosynthesis/processing, protein folding quality control, endoplasmic reticulum homeostasis, autophagy, and wound healing are perturbed. In hEDS cells, gene expression changes related to cell-matrix interactions, inflammatory/pain responses, and acquisition of an in vitro pro-inflammatory myofibroblast-like phenotype may contribute to the complex pathogenesis of the disorder. Finally, emerging findings from miRNA profiling of hEDS fibroblasts are discussed to add some novel biological aspects about hEDS etiopathogenesis.
Overview
CoChat Summary
TL;DR
This review compares transcriptome and protein findings from dermal fibroblasts of patients with classical, vascular, and hypermobile Ehlers‒Danlos syndromes, highlighting shared ECM disarray but distinct pathomechanisms. cEDS and vEDS are linked to collagen V and III defects with perturbed collagen processing, ER homeostasis, autophagy, and wound healing, whereas hEDS/HSD shows cell-matrix, inflammatory/pain, and pro-inflammatory myofibroblast-like changes without a known molecular basis.
Key findings
- The 2017 nosology recognizes 13 EDS subtypes caused by pathogenic variants in 19 genes; cEDS, vEDS, and hEDS account for more than 90% of patients.
- cEDS and vEDS fibroblasts show perturbed collagen biosynthesis/processing, protein folding quality control, ER homeostasis, autophagy, and wound healing; hEDS/HSD cells show altered cell-matrix interactions, inflammatory/pain responses, and an in vitro pro-inflammatory myofibroblast-like phenotype.
- All three cell types share pathological ECM remodeling, but their underlying transcriptional patterns differ, supporting distinct disease mechanisms.
- miRNA profiling of hEDS/HSD fibroblasts identified 19 dysregulated miRNAs, including the most overexpressed miR-378-3p, up-regulated miRNA-224, and reduced miRNA-23a.
Methods
- Narrative review that expands and compares the authors’ previous transcriptome and protein studies on dermal fibroblasts from cEDS, vEDS, and hEDS/HSD patients.
- Data include differential gene expression, ECM protein organization, ER/autophagy markers, inflammatory and myofibroblast-related pathways, and miRNA profiling from patient-derived fibroblasts.
- Main analysis is a comparative synthesis of molecular mechanisms across EDS types; proteome profiling of hEDS/HSD cells is described as currently ongoing.
Limitations
- The paper states that the molecular pathology of these disorders remains poorly studied, the molecular basis of hEDS is unknown, and no validated biological biomarkers have been identified for hEDS/HSD.
- The paper states that additional functional work is needed to establish the involvement of specific proteins and pathways, and that further studies are warranted for ER perturbation in vEDS.
- Evident from the text: this is a narrative review relying largely on prior in vitro fibroblast studies, without a described systematic search or meta-analysis, so findings may not fully reflect in vivo disease mechanisms.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
28 Valid · 1 Not valid · 66 Not checked · 33 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
§ Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes > 5. Altered ECM Turnover, Wound Healing, and Inflammation in cEDS Fibroblasts
What the sources say
- Disputedcites [44] Zoppi N. Gardella R. De Paepe A. Barlati S. Colombi M. Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2β1 integrin, and recruit αvβ3 instead of α5β1 integrin J. Biol. Chem. 2004 30 18157 18168 10.1074/jbc.M312609200 14970208 sourceExperimental — accuracy not yet measured
In the section on collagen organization and integrin clustering, the paper identifies EDSI as classical EDS and states that both EDS cell strains had migration properties comparable to control fibroblasts (Fig. 5). That contradicts reduced in vitro migration in cEDS cells. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Supportedcites [45] Zoppi N. Barlati S. Colombi M. FAK-independent αvβ3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts Biochim. Biophys. Acta 2008 1783 1177 1188 10.1016/j.bbamcr.2008.03.003 18405669 source
The Discussion reports that three EDSI fibroblast strains showed defective migration in a monolayer-wounding assay, supporting the claim of reduced in vitro migration in cEDS cells. It describes this as a finding from an earlier study. (LLM, conf=0.90)
- Not checked yetcites [46] Zoppi N. Ritelli M. Colombi M. Type III and V collagens modulate the expression and assembly of EDA+fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts Biochim. Biophys. Acta 2012 1820 1576 1587 10.1016/j.bbagen.2012.06.004 22705941 source
- Supportedcites [47] Chiarelli N. Carini G. Zoppi N. Ritelli M. Colombi M. Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts PLoS ONE 2019 14 e0211647 10.1371/journal.pone.0211647 30716086 PMC6361458 source
The Introduction states that cEDS patients’ dermal fibroblasts had reduced migration capability in a scratch assay, an in vitro test. The Discussion also describes reduced migratory potential in these cells. (LLM, conf=0.93)
- Supportedcites [48] Viglio S. Zoppi N. Sangalli A. Gallanti A. Barlati S. Mottes M. Colombi M. Valli M. Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1 J. Investig. Dermatol. 2008 128 1915 1919 10.1038/jid.2008.33 18305566 source
The Monolayer wounding assay section reports that, after 48 hours, control fibroblasts had migrated into the scraped area while classical EDS fibroblasts showed a clear delay in scratch repair. It concludes that the cultured EDS fibroblasts had defective migration (p. 1917). (LLM, conf=0.93)
- Supportedcites [49] Zoppi N. Chiarelli N. Binetti S. Ritelli M. Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by αvβ3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders Biochim. Biophys. Acta 2018 1864 1010 1023 10.1016/j.bbadis.2018.01.005 29309923 source
Section 3.1 reports that cEDS dermal fibroblasts showed about twofold less migration than control fibroblasts in a Transwell assay. The Methods (section 2.4) confirm that this was an in vitro migration assay. (LLM, conf=0.94)
- Partly supportedcites [50] Zoppi N. Chiarelli N. Ritelli M. Colombi M. Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes’ Dermal Fibroblasts Int. J. Mol. Sci. 2018 19 982 10.3390/ijms19040982 PMC5979373 29587413 sourceExperimental — accuracy not yet measured
Section 3 says hEDS and HSD fibroblasts have enhanced in vitro migratory capability, in contrast to cEDS and vEDS fibroblasts. That supports a relative difference between EDS subtypes, but it does not establish that cEDS cells have reduced migration compared with control cells. (LLM, conf=0.78)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Recently, a new and very rare EDS variant has been identified that is caused by biallelic mutations in the AEBP1 gene (Table 1) [33,34,35,36].”
§ Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes > 3. Ehlers‒Danlos Syndromes
What the sources say
- Not checked yetcites [33] Blackburn P.R. Xu Z. Tumelty K.E. Zhao R.W. Monis W.J. Harris K.G. Gass J.M. Cousin M.A. Boczek N.J. Mitkov M.V. Bi-allelic alterations in AEBP1 lead to defective collagen assembly and connective tissue structure resulting in a variant of Ehlers-Danlos syndrome Am. J. Hum. Genet. 2018 102 696 705 10.1016/j.ajhg.2018.02.018 29606302 PMC5985336 source
- Not checked yetcites [34] Hebebrand M. Vasileiou G. Krumbiegel M. Kraus C. Uebe S. Ekici A.B. Thiel C.T. Reis A. Popp B. A biallelic truncating AEBP1 variant causes connective tissue disorder in two siblings Am. J. Med. Genet. A 2019 179 50 56 10.1002/ajmg.a.60679 30548383 source
- Not checked yetcites [35] Syx D. De Wandele I. Symoens S. De Rycke R. Hougrand O. Voermans N. De Paepe A. Malfait F. Bi-allelic AEBP1 mutations in two patients with Ehlers-Danlos syndrome Hum. Mol. Genet. 2019 28 1853 1864 10.1093/hmg/ddz024 30668708 source
- Supportedcites [36] Ritelli M. Cinquina V. Venturini M. Pezzaioli L. Formenti A.M. Chiarelli N. Colombi M. Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome Genes. 2019 10 135 10.3390/genes10020135 PMC6410021 30759870 source
The Discussion (p. 1, §4) states that 'a new, autosomal recessive type of EDS has been discovered due to variants in the AEBP1 gene' and that 'this EDS type is very rare', found in only seven individuals from four unrelated families. The Introduction (§1) and Abstract likewise describe recessive (homozygous or compound heterozygous, i.e., biallelic) AEBP1 alterations defining classical-like EDS type 2 (MIM #618000), matching the claim's attribution. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our in vitro findings demonstrated that cEDS patients’ fibroblasts show disassembly of many ECM components, including collagen V and III, fibronectin, and fibrillins, and disorganization of collagen- and fibronectin-specific α2β1 and α5β1 integrin receptors [44,45,46,47].”
§ Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes > 5. Altered ECM Turnover, Wound Healing, and Inflammation in cEDS Fibroblasts
What the sources say
- Supportedcites [44] Zoppi N. Gardella R. De Paepe A. Barlati S. Colombi M. Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2β1 integrin, and recruit αvβ3 instead of α5β1 integrin J. Biol. Chem. 2004 30 18157 18168 10.1074/jbc.M312609200 14970208 source
The section on COL5A1 and COL3A1 mutations reports that EDSI fibroblasts have strongly reduced cell-surface α2β1 and α5β1 integrins. It also describes altered distribution of these receptors in the studied EDS fibroblasts. The paper studied EDSI and EDSIV cells; the EDSI findings support the claim about cEDS fibroblasts. (LLM, conf=0.91)
- Supportedcites [45] Zoppi N. Barlati S. Colombi M. FAK-independent αvβ3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts Biochim. Biophys. Acta 2008 1783 1177 1188 10.1016/j.bbamcr.2008.03.003 18405669 source
The Introduction (page unavailable) identifies EDSI as classical EDS and reports reduced organization of the collagen receptor α2β1 and altered α5β1 organization in the studied EDS fibroblasts. Section 3.1 (page unavailable) also shows that α5β1 was restricted to peripheral contacts in EDSI fibroblasts, unlike its distribution across control cells. (LLM, conf=0.92)
- Not checked yetcites [46] Zoppi N. Ritelli M. Colombi M. Type III and V collagens modulate the expression and assembly of EDA+fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts Biochim. Biophys. Acta 2012 1820 1576 1587 10.1016/j.bbagen.2012.06.004 22705941 source
- Supportedcites [47] Chiarelli N. Carini G. Zoppi N. Ritelli M. Colombi M. Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts PLoS ONE 2019 14 e0211647 10.1371/journal.pone.0211647 30716086 PMC6361458 source
The Results section (‘Aberrant COLLV expression causes the disassembly of different ECM structural proteins’; page not specified) reports that cEDS skin fibroblasts lack collagen- and fibronectin-specific integrin receptors. The paper’s reference [15] identifies those receptors as α2β1 and α5β1. The paper presents the integrin finding as previously demonstrated, rather than as a new measurement in this study. (LLM, conf=0.87)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Its high expression in cEDS cells might represent a transcriptional response in the attempt to counteract, at least in vitro, their reduced migration capability [48,49].”
§ Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes > 5. Altered ECM Turnover, Wound Healing, and Inflammation in cEDS Fibroblasts
What the sources say
- Partly supportedcites [48] Viglio S. Zoppi N. Sangalli A. Gallanti A. Barlati S. Mottes M. Colombi M. Valli M. Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1 J. Investig. Dermatol. 2008 128 1915 1919 10.1038/jid.2008.33 18305566 sourceExperimental — accuracy not yet measured
The Monolayer wounding assay section reports reduced migration and delayed scratch repair in classical EDS fibroblasts. It tests IGFBP-1, not IGFBP2, and does not report high IGFBP2 expression or propose a compensatory transcriptional response. (LLM, conf=0.86)
- Partly supportedcites [49] Zoppi N. Chiarelli N. Binetti S. Ritelli M. Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by αvβ3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders Biochim. Biophys. Acta 2018 1864 1010 1023 10.1016/j.bbadis.2018.01.005 29309923 sourceExperimental — accuracy not yet measured
Section 3.1 reports that cEDS fibroblasts had about twofold lower migration than control fibroblasts in vitro. Our copy does not report high IGFBP2 expression in cEDS cells or propose that it is a transcriptional response to reduced migration (searched: IGFBP2 and insulin-like growth factor binding protein 2). (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
§ Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes > 5. Altered ECM Turnover, Wound Healing, and Inflammation in cEDS Fibroblasts
What the sources say
- Partly supportedcites [44] Zoppi N. Gardella R. De Paepe A. Barlati S. Colombi M. Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2β1 integrin, and recruit αvβ3 instead of α5β1 integrin J. Biol. Chem. 2004 30 18157 18168 10.1074/jbc.M312609200 14970208 sourceExperimental — accuracy not yet measured
The Discussion (page not available) says αvβ3 integrin can act synergistically with the EGF receptor and suggests it might help control growth and survival in EDS cells. It does not demonstrate that this crosstalk occurs in cEDS cells or rescues them from anoikis; the study also includes vascular EDS cells. (LLM, conf=0.88)
- Supportedcites [45] Zoppi N. Barlati S. Colombi M. FAK-independent αvβ3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts Biochim. Biophys. Acta 2008 1783 1177 1188 10.1016/j.bbamcr.2008.03.003 18405669 source
The Introduction identifies EDSI as classical EDS. In Results §3.4 and the Discussion (pages unavailable), the paper reports that αvβ3 integrin and EGFR interact in cultured EDSI fibroblasts and that blocking either receptor induces apoptosis; it concludes that their partnership helps rescue EDS fibroblasts from anoikis. (LLM, conf=0.90)
- Not checked yetcites [46] Zoppi N. Ritelli M. Colombi M. Type III and V collagens modulate the expression and assembly of EDA+fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts Biochim. Biophys. Acta 2012 1820 1576 1587 10.1016/j.bbagen.2012.06.004 22705941 source
- Supportedcites [47] Chiarelli N. Carini G. Zoppi N. Ritelli M. Colombi M. Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts PLoS ONE 2019 14 e0211647 10.1371/journal.pone.0211647 30716086 PMC6361458 source
The Discussion section on ER turnover, protein homeostasis, and autophagy explicitly states that αvβ3 integrin signaling rescues cEDS fibroblasts from anoikis through crosstalk with EGFR. The Discussion’s Fig. 5 summary repeats this mechanism. No page number is provided in the supplied passages. (LLM, conf=0.94)
- Could not verifycites [48] Viglio S. Zoppi N. Sangalli A. Gallanti A. Barlati S. Mottes M. Colombi M. Valli M. Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1 J. Investig. Dermatol. 2008 128 1915 1919 10.1038/jid.2008.33 18305566 sourceExperimental — accuracy not yet measured
The Introduction mentions αvβ3 integrin in an EDS fibroblast strain, but does not describe crosstalk with the EGF receptor. The monolayer wounding assay discusses migration and wound repair, not rescue from anoikis. Searches for anoikis and the EGF receptor found no passage supporting the attributed mechanism. (LLM, conf=0.76)
- Partly supportedcites [49] Zoppi N. Chiarelli N. Binetti S. Ritelli M. Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by αvβ3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders Biochim. Biophys. Acta 2018 1864 1010 1023 10.1016/j.bbadis.2018.01.005 29309923 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that αvβ3 integrin helps rescue cEDS fibroblasts from apoptosis induced by extracellular-matrix disassembly. It does not describe crosstalk with the EGF receptor, so that mechanism is not supported by this source. (LLM, conf=0.86)
- Supportedcites [50] Zoppi N. Chiarelli N. Ritelli M. Colombi M. Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes’ Dermal Fibroblasts Int. J. Mol. Sci. 2018 19 982 10.3390/ijms19040982 PMC5979373 29587413 source
Section 2 states that αvβ3 integrin signaling in cEDS and vEDS fibroblasts rescues them from anoikis through crosstalk with EGFR. Its conclusion also describes this as an in vitro survival mechanism. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 15 with their cited sources checked
Create a free account to see all 128 claims and to verify the 118 references still open.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 16
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In support of this relationship, particularly within the hEDS phenotype, Chiarelli et al. [133] reported that while fibroblasts from classic and vascular EDS patients displayed perturbed collagen biosynthesis and processing, hEDS fibroblasts were typified by a pro-inflammatory myofibroblast-like state, suggesting a process of chronic abnormal wound repair.”
From The Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders (2020) · cites this paper as [133]
In the citing paper
“Therefore, the originating cause in many cases of hEDS may be upstream of collagen synthesis and mediated by the immune system.”
From The Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders (2020) · cites this paper as [133]
Citations
Cites
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 2×
“, CDH2, CDH10, PCDH9, PCDHB16, PCDHB18, claudins (CLDN11), and desmosomes (desmoplakin, DSP), which are involved in the formation of specialized cell-cell junction complexes essential for maintaining epithelial integrity, morphogenesis, and tissue architecture [127,128].”
BackgroundMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
(2008) · doi:10.1038/nrg2290 · Cited by 5,199 · cited 1×
“miRNAs are small non-coding RNA molecules ranging from 20–25 nucleotides in length that act mainly as negative regulators of gene expression by promoting the degradation of target mRNAs or repressing their translation [162,163].”
BackgroundRemodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 1×
“ECM components also modulate immune cell migration into inflamed tissues and their activation and proliferation [23].”
BackgroundThe Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254 · cited 1×
“Prolonged loss of integrin-mediated cell–ECM adhesion leads to anoikis [16].”
BackgroundEpithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649 · cited 1×
“In addition to integrins that primarily mediate this cell response, intracellular signals may be triggered also through the cadherin superfamily, which are calcium-dependent transmembrane proteins forming complex adhesions and connect to the actin cytoskeleton via numerous proteins [125,126].”
BackgroundExtracellular Matrix Degradation and Remodeling in Development and Disease
Lu, P., Takai, K., Weaver, V. M., & Werb, Z. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005058 · Cited by 2,265
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · cited 6×
“The introduction of more selective clinical criteria for hEDS in the novel classification aimed to minimize heterogeneity allows for the formation of homogeneous cohorts to facilitate scientific research to discover the underlying genetic cause(s) of the condition [32].”
BackgroundSelf-citationOverview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
Hynes, R. O., & Naba, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004903 · Cited by 1,349 · cited 1×
“, laminins, elastin, fibronectin, thrombospondins, and tenascins) [4].”
Research works printed but not linked: 1
- Maugeri A. De Paepe A. Malfait F. Genetics and testing of Ehlers-Danlos syndrome and of differential diagnostic diseases Ehlers-Danlos Syndrome: A Multidisciplinary Approach 1st ed. Jacobs J.W.G. Cornelissens L.J.M. IOS Press BV Amsterdam, The Netherlands 2018 Chapter 3 33 46
Cited by
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
The Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders
Casanova, E. L., Baeza-Velasco, C., Buchanan, C. B., & Casanova, M. F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040260 · Cited by 109
Ritelli, M., & Colombi, M. (2020) · Genes · doi:10.3390/genes11050547 · Cited by 69
“[18] offers a wide overview on molecular mechanisms likely involved in cEDS, vEDS, and hEDS that could direct future studies to possible therapeutic strategies.”
BackgroundSelf-citationTendon Extracellular Matrix Assembly, Maintenance and Dysregulation Throughout Life
Siadat, S. M., Zamboulis, D. E., Thorpe, C. T., Ruberti, J. W., & Connizzo, B. K. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-80614-9_3 · Cited by 49
Pain in the Ehlers–Danlos syndromes: Mechanisms, models, and challenges
Malfait, F., Colman, M., Vroman, R., De Wandele, I., Rombaut, L., Miller, R. E., Malfait, A., & Syx, D. (2021) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31950 · Cited by 41
Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome
Omar, R., Malfait, F., & Agtmael, T. V. (2021) · Matrix Biology Plus · doi:10.1016/j.mbplus.2021.100090 · Cited by 43
Extracutaneous features and complications of the Ehlers-Danlos syndromes: A systematic review
Doolan, B. J., Lavallee, M. E., Haußer, I., Schubart, J. R., Pope, F. M., Seneviratne, S. L., Winship, I., & Burrows, N. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1053466 · Cited by 33
“Decreased levels of this miRNA were also found in cerebrospinal fluid and serum of patients with fibromyalgia (38), implying a possible involvement of specific miRNA signatures or a common disease pattern in both conditions (16).”
BackgroundEhlers-Danlos syndromes and their manifestations in the visual system
Asanad, S., Bayomi, M., Brown, D., Buzzard, J., Lai, E. W., Ling, C. J. M., Miglani, T., Mohammed, T. K., Tsai, J., Uddin, O., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.996458 · Cited by 37
“showed that hEDS fibroblasts exhibited dysregulated gene expression of extra cellular matrix glycoproteins such as elastin, suggesting matrix dysfunction as a potential mechanism (45).”
BackgroundImpaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome
Dmitrieva, N. I., Walts, A. D., Nguyen, D. P., Grubb, A. F., Zhang, X., Wang, X., Ping, X., Jin, H. Z., Yu, Z., Yu, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135490 · Cited by 33
“Thus, patients with Ehlers-Danlos syndromes, caused by mutations in collagens, present with joint hyperextensibility, facial dysmorphism, frequent fractures, aneurysms, and impaired wound healing that resemble some of the AD-HIES nonimmunological abnormalities (39, 41, 42).”
BackgroundA Spatiotemporal Controllable Biomimetic Skin for Accelerating Wound Repair
Chen, Y., Lu, W., Zhou, Y., Hu, Z., Wu, H., Gao, Q., Shi, J., Wu, W., Lv, S., Yao, K., et al. (2024) · Small · doi:10.1002/smll.202310556 · Cited by 25
Ritelli, M., Chiarelli, N., Cinquina, V., Bertini, V., Piantoni, S., Caproli, A., Pina, S. E. L. D., Franceschini, F., Zarattini, G., Gandy, W., et al. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63857 · Cited by 29
“Our prior efforts aimed to address this unmet need through comprehensive omics analyses in a large cohort of hEDS and HSD dermal fibroblasts (Chiarelli et al. 2019; Chiarelli, Zoppi, Ritelli, et al. 2021; Chiarelli, Zoppi, Venturini, et al. 2021; Ritelli et al. 2022; Zoppi et al. 2018).”
Self-citationThe Aortic Pathologies: How Far We Understand It and Its Implications on Thoracic Aortic Surgery
Harky, A., Sokal, P. A., Hasan, K., & Papaleontiou, A. (2020) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2020-0089 · Cited by 29
Hypermobile Ehlers-Danlos syndrome and spontaneous CSF leaks: the connective tissue conundrum
Severance, S., Daylor, V., Petrucci, T., Gensemer, C., Patel, S. M., & Norris, R. A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1452409 · Cited by 24
Current management of the vascular subtype of Ehlers–Danlos syndrome
Benrashid, E., & Ohman, J. W. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000797 · Cited by 24
“Type III collagen has also been shown to have a regulatory role in the secretion of fibrils containing type I collagen, along with decreases in expression of the essential extracellular matrix (ECM) component, fibrillin [13].”
BackgroundBiomarkers for Ehlers-Danlos Syndromes: There Is a Role?
Caliogna, L., Guerrieri, V., Annunziata, S., Bina, V., Brancato, A. M., Castelli, A., Jannelli, E., Ivone, A., Grassi, F. A., Mosconi, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810149 · Cited by 24
“This suggests how AQP9 may have a role in the pathogenesis of inflammatory synovitis [4].”
BackgroundInfluentialLiu, Y., Wang, L., Cheng, X., Huo, Y., Ouyang, X., Liang, L., Lin, Y., Wu, J., Ren, J., & Guleng, B. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14236 · Cited by 20
Malek, S., & Köster, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.649082 · Cited by 21
Chiarelli, N., Zoppi, N., Venturini, M., Capitanio, D., Gelfi, C., Ritelli, M., & Colombi, M. (2021) · Cells · doi:10.3390/cells10113236 · Cited by 20
Self-citationMechanobiology in the Comorbidities of Ehlers Danlos Syndrome
Royer, S. P., & Han, S. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.874840 · Cited by 20
Mindin (SPON2) Is Essential for Cutaneous Fibrogenesis in a Mouse Model of Systemic Sclerosis
Rana, I., Kataria, S., Tan, T. L., Hajam, E. Y., Kashyap, D. K., Saha, D., Ajnabi, J., Paul, S., Jayappa, S., Ananthan, A. S., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.10.011 · Cited by 18
COL1A1 and COL1A2 variants in Ehlers‐Danlos syndrome phenotypes and COL1 ‐related overlap disorder
Venable, E. R., Knight, D. R. T., Thoreson, E. K., & Baudhuin, L. M. (2023) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32038 · Cited by 20
“The Ehlers-Danlos syndromes encompass a group of hereditary connective tissue disorders currently consisting of 13 named subtypes associated with at least 19 different genes (Chiarelli et al., 2019; Malfait et al., 2017).”
BackgroundHadar, N., Porgador, O., Cohen, I., Levi, H., Dolgin, V., Yogev, Y., Sued-Hendrickson, S., Shelef, I., Didkovsky, E., Eskin‐Schwartz, M., et al. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01559-1 · Cited by 20
Genetic Determinants of Wound Healing: Monogenic Disorders and Polygenic Influence
Mueller, S. M., Miller, N., Gill, J., Yu, L. C., PIKE, M. M., & Orgill, D. P. (2026) · Cells · doi:10.3390/cells15010074 · Cited by 18
“In mutant forms, these gene variants lead to functionally defective collagens, resulting in structural defects and tissue fragility [28].”
InfluentialLiu, L., Jouve, C., Henry, J., Berrandou, T.-E., Hulot, J., Georges, A. B., & Bouatia‐Naji, N. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.19733 · Cited by 15
Omar, R., Lee, M. A., Gonzalez-Trueba, L., Thomson, C. R., Hansen, U. J., Lianos, S., Hazarika, S., Abdallah, O. H. E., Ammar, M. A., Cassels, J. E., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02476-y · Cited by 15
Doolan, B. J., Lavallee, M. E., Haußer, I., Pope, F. M., Seneviratne, S. L., Winship, I., & Burrows, N. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.01.034 · Cited by 13
Jacinto, J. G. P., Häfliger, I. M., Veiga, I. B., Letko, A., Benazzi, C., Bolcato, M., & Drögemüller, C. (2020) · Animals · doi:10.3390/ani10112002 · Cited by 12
“Human EDS forms are grouped based on the underlying pathogenetic mechanisms related to primary structure and processing of collagen (COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, ADAMTS2), collagen folding and cross-linking (PLOD1, FKBP14), structure and function of the myomatrix (TNXB, COL12A1), glycosaminoglycan biosynthe…”
BackgroundFoehr, R. M., Anderson, K., Dombrowski, O., Foehr, A., & Foehr, E. D. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-03007-7 · Cited by 13
“For example, mutations that alter glycine amino acid residues in Collagen III correlate with more severe disease [4, 5].”
BackgroundGariballa, N., Mohamed, F. E., Badawi, S., & Ali, B. R. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01054-1 · Cited by 11
Awad, A. A., Yappalparvi, A., Khatib, M. N., Roopashree, R., Kaur, M., Srivastava, M., Barwal, A., Prasad, G. V. S., Rajput, P., Syed, R., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03854-6 · Cited by 10
“The pathogenicity of these mutations is further exacerbated by dysregulated transforming growth factor-beta (TGF-β) signaling, which promotes extracellular matrix remodeling and contributes to vascular fragility [42–44].”
Fiengo, E., & Sbarbati, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207195 · Cited by 9
“In this latter condition, we have found that the hyperlaxity is linked to the specific alteration of fibroblasts (Chiarelli, 2019) [29].”
Genomic Characterization by Whole-Exome Sequencing of Hypermobility Spectrum Disorder
Alanis-Funes, G. J., Lira-Albarrán, S., Hernández-Pérez, J., Garza‐Elizondo, M. A., Ortíz-López, R., Elizondo-Solís, C., Rojas‐Martínez, A., Chávez-Santoscoy, R. A., & Rangel‐Escareño, C. (2022) · Genes · doi:10.3390/genes13071269 · Cited by 9
Putotto, C., Pulvirenti, F., Pugnaloni, F., Isufi, I., Unolt, M., Anaclerio, S., Caputo, V., Bernardini, L., Messina, E., Moretti, C., et al. (2022) · Genes · doi:10.3390/genes13122334 · Cited by 9
“To date, it is known that the extracellular matrix (ECM) has a major functional role in ensuring the integrity and function of various connective tissues (such as bone, cartilage and blood vessels) and is implicated in the etiopathogenesis of hereditary connective tissue disorders (such as Ehlers–Danlos syndrome) [13,…”
BackgroundJoint Hypermobility Syndrome and Membrane Proteins: A Comprehensive Review
Pliego-Arreaga, R., Cervantes‐Montelongo, J. A., Silva-Martínez, G. A., Tristán-Flores, F. E., Pantoja-Hernández, M. Á., & Maldonado-Coronado, J. R. (2024) · Biomolecules · doi:10.3390/biom14040472 · Cited by 9
“They are abundantly expressed during embryonic development, wound healing, and tissue renewal [32].”
BackgroundInfluentialPrentice, D. A., Pearson, W. A., & Fogarty, J. (2021) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000741524.79369.7a · Cited by 8
“Any abnormality in the ECM is reflected in poor cellular growth, migration, and orientation, as well as inferior biomechanical strength affecting tissue stability.(24) The transcriptome of EDSv dermal fibroblasts show reduced transcription of proteins involved in ECM (fibrillin, periostin, and collagen I and III) and…”
BackgroundHart, D. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031256 · Cited by 8
The Role of Cutaneous Manifestations in the Diagnosis of the Ehlers-Danlos Syndromes
Stembridge, N. S., Doolan, B. J., Lavallee, M. E., Haußer, I., Pope, F. M., Seneviratne, S. L., Winship, I., & Burrows, N. (2022) · Skin Health and Disease · doi:10.1002/ski2.140 · Cited by 7
“Over 90% of cEDS cases are caused by heterozygous pathogenic variants in COL5A1 or COL5A2, which dysregulate the collagen assembly of fibrillar collagens.(5) A specific mutation (p.”
BackgroundChiarelli, N., Cinquina, V., Martini, P. G. V., Bertini, V., Zoppi, N., Venturini, M., Ritelli, M., & Colombi, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166915 · Cited by 8
“Protein studies showed that the altered distribution of the ER marker protein disulfide isomerase PDI, along with decreased levels of the COLLs-modifying enzyme FKBP22 [12,13], were consistent with disturbance in ER-related homeostasis and anomalies in collagen fiber structure and size [14].”
Self-citationB3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome
Diana, R., Jolivet, B., Vincourt, J., Hergalant, S., Francius, G., Karami, Y., Khakzad, H., Wild, R., Bourgeais, M., Robert, A., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.179474 · Cited by 6
“…EDS hypermobility type (JHS/EDS-HT) (30), PMID: 27518164, GSE77753), (c) a group with vascular EDS (vEDS) (31), PMID: 29346445, GSE102042), and (d) a cohort of patients suffering from classical EDS (cEDS) (32), PMID: 30716086, GSE117680), which carry distinct but overlapping symptoms with spEDS.”
Shirvani, A., Shirvani, P., & Holick, M. F. (2026) · Genes · doi:10.3390/genes17020211 · Cited by 7
“…enrichment of COL5A1 , COL18A1 , and COL17A1 along with modification enzyme genes PLOD1-3 is consistent with a role for collagen-related genes [13,30,31], though the absence of identifiable collagen variants in 37% of our hEDS cohort suggests that additional genetic factors may contribute to…”
Wang, C., Fan, M., Heo, S., Adams, S. M., Li, T., Liu, Y., Li, Q., Loebel, C., Burdick, J. A., Lu, X. L., et al. (2025) · Advanced Science · doi:10.1002/advs.202414750 · Cited by 6
Anderson, L. K., & Lane, K. R. (2023) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000900 · Cited by 6
“Research suggests that hEDS/HSD, like other EDS types, alters the collagen fi bers and extracellular matrix of the connective tissues responsible for joint, blood vessel, skin, and organ system integrity (Chiarelli et al., 2019).”
BackgroundGauthier, A. C., Bower, K. S., & Singman, E. L. (2022) · Cornea · doi:10.1097/ico.0000000000003028 · Cited by 5
Nikolaeva, E. A., & Semyachkina, A. N. (2021) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2021-66-1-22-30 · Cited by 5
Al‐Harbi, T., Al‐Rammah, H., Al‐Zahrani, N., Liu, Y., Abou‐Sleiman, P. M., Dridi, W., & Hakonarson, H. H. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62539 · Cited by 6
Miller, M. E. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110859 · Cited by 5
Chiarelli, N., Cinquina, V., Zoppi, N., Bertini, V., Maddaluno, M., Leonibus, C. D., Settembre, C., Venturini, M., Colombi, M., & Ritelli, M. (2024) · Biomedicines · doi:10.3390/biomedicines12122749 · Cited by 4
Self-citationSølyst, S., Oksjoki, R. K., Farholt, S., Nielsen, D. G., Christensen, A. H., Fagerberg, C. R., Risom, L., Gregersen, P. A., Christensen, M. B., Rasmussen, T. B., et al. (2022) · Clinical Genetics · doi:10.1111/cge.14176 · Cited by 4
“The abnormal folding of the triple helices results in a dominant-negative effect with an 87% reduction in the production of structurally normal type III collagen, whereas haploinsufficiency theoretically only reduces the amount by 50%.(12,13)”
BackgroundMiolo, G., Machin, P., Conto, M. D., Fortuna, S., Viglio, S., Puppa, L. D., Geremia, S., & Corona, G. (2025) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70095 · Cited by 3
Fodor, R., Marlar, R., Ku, Y. C., Al‐Malak, M., Jensen, K. N., Lammers, J., Khalaf, R., Meyers, A., Rampazzo, A., & Gharb, B. B. (2025) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000012205 · Cited by 3
Mindin regulates fibroblast subpopulations through distinct Src family kinases during fibrogenesis
Kataria, S., Rana, I., Badarinath, K., Zaarour, R. F., Kansagara, G., Ahmed, S., Rizvi, A., Saha, D., Dam, B., Dutta, A., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.173071 · Cited by 3
Manifestations respiratoires des syndromes d’Ehlers-Danlos
Benattia, A., Bénistan, K., Frank, M., & Boussouar, S. (2023) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2023.01.009 · Cited by 3
Shirvani, A., Shirvani, P., Jonah, U., Moore, B. E., & Holick, M. F. (2025) · Biomedicines · doi:10.3390/biomedicines13020469 · Cited by 2
“The ECM disorganization observed in hEDS cells may be a consequence of excessive pathological turnover, mainly due to ECM-degrading enzymes and other unknown factors [15].”
InfluentialManhas, J., Lohani, L. R., Seethy, A. A., Kumar, U., Gamanagatti, S., & Sen, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.939013 · Cited by 2
“Previous studies have reported an inefficient secretion of mutant collagen molecules which can lead to altered structural anatomy of the endoplasmic reticulum and unfolded protein response (14).”
BackgroundThe Association Between Hypermobility Ehlers–Danlos Syndrome and Other Rheumatologic Diseases
Makol, A., Chakravorty, B., Heller, M., & Riley, B. A. (2021) · European Medical Journal · doi:10.33590/emj/21-00078r2 · Cited by 2
Liao, Z., Zhao, T., Wang, N., Chen, J., Sun, W., & Wu, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.834928 · Cited by 2
“Previous studies (Chiarelli et al., 2016, 2018, 2019; Lim et al., 2019) performed transcriptome analysis on other EDS subtypes, which succeeded FIGURE 1 | The correlation between pEDS and control group was evaluated by quality assessment methods including principal component analysis (PCA) and…”
MethodResultMultiple Dermatomyofibromas in a Patient with Ehlers-Danlos Syndrome
Derbyshire, M., Brady, A., & Farah, R. S. (2023) · Case Reports in Dermatology · doi:10.1159/000530423 · Cited by 1
“Both in vitro studies of cultured fi broblasts collected from patients and transcriptomic studies of patient samples demonstrate that fi broblasts derived from hypermobile EDS patients have a signi fi cantly increased propensity for fi broblast-to-myo fi broblast transition [11, 12].”
BackgroundHart, D. A. (2026) · Results and problems in cell differentiation · doi:10.1007/978-3-032-19509-8_13 · Cited by 2
Aspecte clinice şi genetice în cadrul sindromului Ehlers Danlos
Shelby, E.-S., Leanca, M. C., Hamei, Ș., Pădure, L., Universitatea de Medicină şi Farmacie „Carol Davila“, B., Mirea, A., & Universitatea de Medicină şi Farmacie „Carol Davila“, B. (2020) · Romanian Journal of Pediatrics · doi:10.37897/rjp.2020.4.18 · Cited by 1
“Colagenul este o proteină fibrilară prezentă în structura țesutului conjunctiv uman, îndeosebi la nivelul articulațiilor, al pielii și al oaselor (10,11), fiind cea mai abundentă proteină a matricei extracelulare (10,12) și, totodată, cea mai abundentă proteină din organism, unde are un rol esențial în menținerea stru…”
Asthenia Cutanea in Albino Burmese Python (Python Molurus Bivittatus): Report of a Case in Mexico
Cisneros, J. S. S., Gámez, B. A. F., Kane, M. H. R., Contreras, L. M., & Núñez, C. R. (2021) · Research Journal for Veterinary Practitioners · doi:10.17582/journal.rjvp/2022/10.1.1.3 · Cited by 1
Höpperger, S., Spathopoulou, A., Mayer‐Suess, L., Cubero, M. S., Sillaber, K., Spreiz, A., Kiechl, S. J., Edenhofer, F., & Fellner, L. (2024) · Stem Cell Research · doi:10.1016/j.scr.2024.103321 · Cited by 1
The Effect of Joint Hypermobility Syndrome on DOMS and Recovery Time
Ostuni, N. F., Marinello, C. A., Luzhnyy, T., Pawlikowski, A., Vlasaty, C., Thomatos, G., & Douris, P. C. (2024) · International Journal of Sports Physical Therapy · doi:10.26603/001c.91644 · Cited by 1
Broken Connections: The Evidence for Neuroglial Failure in ME/CFSPreprint
Renz‐Polster, H. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/ef3n4 · Cited by 1
Skin and Lacrimal Drainage System
Yanoff, M., & Sassani, J. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-87822-7.00006-7 · Cited by 1
Clinical and genetic aspects in the Ehlers Danlos syndrome
Shelby, E.-S., Leanca, M. C., Hamei, Ș., Pădure, L., & Mirea, A. (2020) · Romanian Journal of Pediatrics · doi:10.37897/rjp.2020.4.17
Annular elastolytic giant cell granuloma in a patient with Ehlers–Danlos syndrome
Gaydina, T. A., Игоревна, П. О., & Tairova, R. T. (2022) · Vestnik dermatologii i venerologii · doi:10.25208/vdv1338
A Case of Vascular Ehlers-Danlos Syndrome Presenting with Multiple Cerebral Arterial Dissections
Yang, B. S. K., Lee, B., Ko, Y., & Kim, J. Y. (2022) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2022.4.4
Manejo odontológico de pacientes con el síndrome de Ehlers-Danlos. Revisión narrativa
Cancino, J., Gutiérrez, S., & Escobar, D. F. (2023) · Rev. Asoc. Odontol. Argent · doi:10.52979/raoa.1110851.1213 · Cited by 1
Anderson, L. K. (2023) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/98741
Ehlers-Danlos syndrome: From bedside to bench
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4557-7
Genomic analysis of mobility measures on 5-month-old gilts associated with structural soundness
Ostrand, L. M., Rempel, L. A., Keel, B. N., Snelling, W. M., Schmidt, T. B., Psota, E. T., Mote, B. E., & Rohrer, G. A. (2025) · Journal of Animal Science · doi:10.1093/jas/skaf001
Christoforou, M. E., Lum, Y. W., Sroge, S. C., Azola, A. M., & Rowe, P. C. (2025) · Cureus · doi:10.7759/cureus.90494
Classical Ehlers-Danlos Syndrome
DePace, N. L., Soloway, S., Yayac, M. F., & Colombo, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88769-7_8
Hypermobilität – Stellenwert in der Rheumatologie
Braun, J. (2025) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-025-01707-y
“Mit 28 unter-schiedlichen Typen sind Kollagene die häufigsten Proteine in der ECM [27, 28].”
Foehr, R. M., Anderson, K., Dombrowski, O., Foehr, A., & Foehr, E. D. (2024) · Figshare · doi:10.6084/m9.figshare.26663056
Foehr, R. M., Anderson, K., Dombrowski, O., Foehr, A., & Foehr, E. D. (2024) · Figshare · doi:10.6084/m9.figshare.26663059
Curry-Koski, T., & Curry-Koski, T. (2024) · UA Campus Repository (The University of Arizona)
Impact gynécologique du syndrome d'Ehlers-Danlos : focus sur les dysménorrhées
Lecointre, M. (2025) · HAL
Streb, L., McKenzie, E. C., Finno, C. J., Stieger‐Vanegas, S. M., Löhr, C. V., Gruenwald, R., & White, C. N. (2026) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.25.12.0790
Kim, J., Lee, H.-Y., Kim, S.-Y., Lee, S. H., Cho, M., Shin, J. W., Yoon, Y. D., Lee, J., Kang, Y. E., Kang, D. H., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103881
“The pathways implicated by these recurrently mutated genes—ECM remodeling, TGF-β /BMP signaling, ECM structural components, cytoskeleton regulation, and ion channel function—represent core biological pathways underlying hEDS pathophysiology [27,28].”
InfluentialOphthalmic Implications of Ehlers-Danlos Syndrome
Zhang, K. R., Zhang, X., Xu, K., Kojima, J., Anderson, B. D., Dunaief, J. L., & Armenti, S. T. (2026) · Clinical ophthalmology · doi:10.2147/opth.s600529
“10 These elevated myopia prevalences align with previous reports, 4,5 potentially reflecting abnormal scleral or corneal extracellular matrix 32 leading to axial elongation and corneal refractive aberration.”
Baird, D. A., Pidlisnyuk, N., Matischen, A., Matelowska, Z., Seo, S., Supari, N., Bowen, J., Sobey, G. J., & Balasubramanian, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.03.736265
Cox, C., Unruh, A., Wagner, B., Escobar, G. P., Walsh, C., Jastrzemski, O., Henderson, I., & DeAguero, J. L. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1846464
“The coexistence of hypermobile Ehlers-Danlos syndrome in this patient raises questions regarding the potential role of connective tissue biology in those who experience gadolinium-associated symptoms (Malfait et al., 2017; Chiarelli et al., 2019; Semelka and Ramalho, 2023).”
Bohling‐Davis, E. (n.d.) · UWE Research Repository (UWE Bristol)
Hypermobile Ehlers-Danlos Syndrome and widespread pain: Beyond structural laxity
Weisman, A., & Masharawi, Y. (2026) · Joint Bone Spine · doi:10.1016/j.jbspin.2026.106126
闰珂珂, Yuan, Y., Wen, X., Hu, X., & Zhu, D. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1883212
The significance of hypermobility syndromes for rheumatology
Braun, J. (2026) · Exploration of Musculoskeletal Diseases · doi:10.37349/emd.2026.1007139
Metadata
- Authors
- Chiarelli, N., Ritelli, M., Zoppi, N., & Colombi, M.
- Affiliations
- University of Brescia (IT)
- Corresponding author
- Colombi, Marina
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2019-08-12
- Volume
- 10
- Issue
- 8
- Pages
- 609
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC6723307
- OpenAlex
- W2968654896
- Semantic Scholar
- 9e41afdb065dbae9022bfb44d98b650ae9514fa2
- Cited by
- 82
- References
- 182
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 15 · 2021: 12 · 2020: 9 · 2019: 1
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Health Sciences › Dentistry › Periodontics › Oral and gingival health research
- Keywords
- Ehlers-Danlos syndrome, classical Ehlers-Danlos syndrome, vascular Ehlers-Danlos syndrome, hypermobile Ehlers-Danlos syndrome, connective tissue diseases, dermal fibroblasts, type V collagen, type III collagen, extracellular matrix remodeling, collagen synthesis, protein folding quality control, endoplasmic reticulum homeostasis, autophagy, wound healing, cell-matrix interactions, inflammation, pain, miRNA expression profiling, pathogenesis
- MeSH terms
- Animals, Autophagy, Ehlers-Danlos Syndrome, Extracellular Matrix, Fibroblasts, Humans, Wound Healing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
